Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cash for walks: small study tests incentives to fight obesity

NCT ID NCT02945332

Knowledge-focused Sponsor: Texas Tech University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether giving financial rewards for walking and healthy food could help low-income adults with obesity or diabetes. Eight participants were split into two groups: one received incentives, the other did not. The goal was to see if this approach could reduce disease burden and be cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
financial incentive and supervised walking
What this could lead to
If successful, this could point toward a low-cost way to help low-income communities reduce obesity and diabetes through exercise and better food choices.
What could go wrong
This is a very small pilot study with only 8 participants, so results may not apply to larger populations. The study is complete, but no major outcomes were reported.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Oct 2016

Finished

Dec 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Sedentary (\< 3 hours/week of moderate intensity physical activity), and otherwise healthy men and women 2. Willingness to: follow the instructions, and to attend regularly, 3. BMI 25 - 50 kg/M2 4. Age: 18y - 65 y. Subjects will be screened prior to the study. Exclusion Criteria: 1. Significant cardiac disease in the past 6 months (Myocardial Infarction, angioplasty, Congestive Heart Failure, Left Bundle Branch Block, 3rd degree AV- block, CABG), 2. Uncontrolled hypertension (systolic BP \> 180 or diastolic BP \> 105 mm Hg), 3. Medications that could interfere with outcomes and that could not be safely withdrawn prior to testing, 4. Pregnancy or intention to conceive during the study period, 5. Current substance abuse, 6. Indications of potential difficulties adhering to the protocol, 7. Subjects who in the opinion of the investigators are inappropriate for study participation or who would be at additional risk by participating, 8. Physical or medical limitation for exercise, intermittent claudication, severe back pain or spasm, inability to ambulate independently or without the use of a cane or walker, 9. Unexcused absence for more than 2 continuous weeks, irregular attendance, non-cooperation, conception, or change in the health status that would jeopardize the subject could be grounds for expulsion from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior diabetes mellitus Motor Activity Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus Obesity

Contacts and locations

Locations

  • Lubbock Dream Center

    Lubbock, Texas, 79411, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.